Tr1x

Tr1X ist ein Pionier in einer revolutionären Kategorie regulatorischer T-Zell-basierter Produkte zur Heilung von Autoimmun- und Entzündungskrankheiten mit dem Potenzial, das Leben der Patienten deutlich zu verbessern.

Land

USA

Webseite

tr1x.bio

Gegründet

2018

Soziale Medien

Informationsquelle:

www.tr1x.bio/

Zu meiner Liste hinzufügen

Wichtige Führungskräfte

Bill Lis

Chief Executive Officer

Maria Grazia Roncarolo, MD

Co-founder, President and Head of R&D

David de Vries, MPhil

Co-founder, Chief Operating Officer

Branchen

Med Tech

Fügen Sie Ihr Unternehmen hinzu

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.